ALTG 09/005 TROG 09.02 CHISEL: Phase III randomised trial of highly conformal hypfractionated image guided (“stereotactic”) radiotherapy vs conventionally fractionated radiotherapy for inoperable early stage I NSCLC – The Australasian Lung Cancer Trials Group (ALTG)

ALTG 09/005 TROG 09.02 CHISEL: Phase III randomised trial of highly conformal hypfractionated image guided (“stereotactic”) radiotherapy vs conventionally fractionated radiotherapy for inoperable early stage I NSCLC

CHISEL is now closed to accrual. This phase III trial is a TROG study endorsed and co-badged by ALTG. Patients with T1 and T2A N0 non-small cell lung cancer are randomised to hypofractionated stereotactic ablative radiotherapy (either 54 Gy in 3 fractions or 48 Gy in 4 fractions) versus conventionally fractionated radiotherapy 66 Gy in … Continue reading ALTG 09/005 TROG 09.02 CHISEL: Phase III randomised trial of highly conformal hypfractionated image guided (“stereotactic”) radiotherapy vs conventionally fractionated radiotherapy for inoperable early stage I NSCLC